Symbol="RVNC"
AssetType="Common Stock"
Name="Revance The"
Description="Revance Therapeutics, Inc., a biotechnology company, is dedicated to the development, manufacture, and marketing of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company is headquartered in Newark, California."
CIK="1479290"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="7555 GATEWAY BLVD., NEWARK, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1636850000"
EBITDA="-238327008"
PERatio="None"
PEGRatio="-0.64"
BookValue="0.305"
DividendPerShare="0"
DividendYield="0"
EPS="-4.6"
RevenuePerShareTTM="2.35"
ProfitMargin="-1.919"
OperatingMarginTTM="-1.479"
ReturnOnAssetsTTM="-0.297"
ReturnOnEquityTTM="-29.62"
RevenueTTM="186401000"
GrossProfitTTM="-20388000"
DilutedEPSTTM="-4.6"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.049"
AnalystTargetPrice="39.27"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="16.29"
PriceToBookRatio="12.3"
EVToRevenue="16.96"
EVToEBITDA="-7.93"
Beta="0.753"
num_52WeekHigh="37.98"
num_52WeekLow="16.93"
num_50DayMovingAverage="23.16"
num_200DayMovingAverage="27.51"
SharesOutstanding="87955000"
DividendDate="None"
ExDividendDate="None"
symbol="RVNC"
open="18.70"
high="18.96"
low="18.05"
price="18.61"
volume="1275478.00"
latest_trading_day="2023-08-23"
previous_close="17.89"
change="0.72"
change_percent="4.0246%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="66"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="34"
Volume_recent_avg="1368091"
Change_recent_avg="-0.1"
Delta_recent_avg="1.28"
Variance_recent_avg="0.64"
Change_ratio_recent_avg="-0.55"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="34"
Aroon_momentum_negative="66"
image_negative_thumbnail_id_1="142"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0034.jpeg"
image_negative_thumbnail_id_2="1137"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0170.jpeg"
image_neutral_thumbnail_id_1="563"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_neutral_thumbnail_id_2="553"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_positive_thumbnail_id_1="623"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0085.jpeg"
image_positive_thumbnail_id_2="653"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0055.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
